Yagolovich, A.V.; Artykov, A.A.; Isakova, A.A.; Vorontsova, Y.V.; Dolgikh, D.A.; Kirpichnikov, M.P.; Gasparian, M.E.
Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity. Int. J. Mol. Sci. 2022, 23, 5860.
https://doi.org/10.3390/ijms23115860
AMA Style
Yagolovich AV, Artykov AA, Isakova AA, Vorontsova YV, Dolgikh DA, Kirpichnikov MP, Gasparian ME.
Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity. International Journal of Molecular Sciences. 2022; 23(11):5860.
https://doi.org/10.3390/ijms23115860
Chicago/Turabian Style
Yagolovich, Anne V., Artem A. Artykov, Alina A. Isakova, Yekaterina V. Vorontsova, Dmitry A. Dolgikh, Mikhail P. Kirpichnikov, and Marine E. Gasparian.
2022. "Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity" International Journal of Molecular Sciences 23, no. 11: 5860.
https://doi.org/10.3390/ijms23115860
APA Style
Yagolovich, A. V., Artykov, A. A., Isakova, A. A., Vorontsova, Y. V., Dolgikh, D. A., Kirpichnikov, M. P., & Gasparian, M. E.
(2022). Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity. International Journal of Molecular Sciences, 23(11), 5860.
https://doi.org/10.3390/ijms23115860
